Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This pharmaceutical grade peptide shows superior efficacy in glucose control and weight management compared to single receptor agonists.
The tirzepatide UK price reflects its high purity (99.9%) and pharmaceutical grade quality. Each vial contains precisely measured 10mg of active peptide compound, packaged in secure 10vial/box quantities suitable for research applications.
Clinical studies demonstrate tirzepatide's remarkable weight loss potential, with trial participants achieving 15-20.9% body weight reduction over 72 weeks. The compound's unique dual agonist mechanism combines the benefits of both GIP and GLP-1 receptor activation in a single molecule.
For researchers seeking the best tirzepatide UK price, we offer bulk quantities with customizable packaging options. Our pharmaceutical-grade product undergoes rigorous quality control to ensure batch-to-batch consistency and optimal performance in research settings.
The competitive tirzepatide UK price makes this innovative compound accessible for diabetes and obesity research projects. As a once-weekly administration compound, tirzepatide offers convenience alongside its demonstrated metabolic benefits in clinical trials.
Note: This product is for research use only. Not for human consumption. Proper storage conditions (cool, dry, dark environment) are essential to maintain peptide stability and efficacy.